Based on our data and current literature, we propose a central role for ILC2 as an inflammatory sentinel producing IL13 not only in response primarily to IL25, but also to local accumulation of the alarmin IL33, consistent with findings that genetic ablation of either Il33 or Il13 expression prevented the formation of experimentally induced gastric metaplasia. The gene discussed is IL33; the disease is Gastric Metaplasia.